Your browser doesn't support javascript.
loading
Research Advances in Ocular Myasthenia Gravis / 中国医学科学院学报
Ya-Jun WU; Li YAN; Yu-Xiang HU; Jie RAO; Xiao-Xuan XU; Yi CHENG; Na WU; Xiao-Rong WU.
Zhongguo yi xue ke xue yuan xue bao ; Zhongguo yi xue ke xue yuan xue bao;(6): 402-407, 2019.
Article in Zh | WPRIM | ID: wpr-776019
Responsible library: WPRO
ABSTRACT
Ocular myasthenia gravis(OMG)is an autoimmune disease caused by neuromuscular junction transmission disorders and manifested mainly as fluctuating blepharoptosis and diplopia,with the extraocular muscles as the main involveed sites.While the pathogenesis of OMG remains unclear,some antibodies,complements,and cytokines may be the contributing factors.The diagnosis and treatment of OMG have been defined in recent years.This article reviews the pathogenesis,diagnosis,and treatment of OMG.
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Index: WPRIM Main subject: Pathology / Therapeutics / Complement System Proteins / Cytokines / Diagnosis / Antibodies / Myasthenia Gravis / Oculomotor Muscles Type of study: Diagnostic_studies Limits: Humans Language: Zh Journal: Zhongguo yi xue ke xue yuan xue bao Year: 2019 Type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google
Full text: 1 Index: WPRIM Main subject: Pathology / Therapeutics / Complement System Proteins / Cytokines / Diagnosis / Antibodies / Myasthenia Gravis / Oculomotor Muscles Type of study: Diagnostic_studies Limits: Humans Language: Zh Journal: Zhongguo yi xue ke xue yuan xue bao Year: 2019 Type: Article